Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 454 shares of common stock on March 27, 2024, to cover tax withholding obligations.

Summary

  • On March 27, 2024, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 454 shares of the company's common stock.
  • The sale was executed at a price of $17.99 per share.
  • The transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted by Mathew on March 25, 2020.
  • The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock shares.
  • Following the transaction, Mathew directly owns 319,682 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document describes a routine stock sale for tax purposes, which is neutral in sentiment. It doesn't indicate any positive or negative outlook for the company.

Industry Context

This is a routine transaction for executives to manage their tax liabilities related to stock-based compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

  • The sale of shares by an executive could have a minor impact on shareholder sentiment, but the impact is likely to be minimal given the small number of shares sold and the pre-planned nature of the transaction.

Key Dates

DateDescription
03-25-2020Effective date of the Rule 10b5-1(c) trading plan adopted by the reporting person.
03/27/2024Date of the transaction: sale of 454 shares of common stock.
03/29/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.